Funding for this research was provided by:
Natural Science Foundation of China (81771359, 81471280 and 81271401)
Guangdong Provincial Science and Technology Plan (2014A020212130)
Guangzhou City Science and Technology Plan (1561000153(201508020012))
National Key Clinical Department and Key Discipline of Neurology, the Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases (2014B030301035)
Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003)
Guangdong Provincial Engineering Center for Major Neurological Disease Treatment, Science and Technology Planning Project of Guangzhou (201604020010)
Major Medical Collaboration and Innovation Program of Guangzhou Science Technology and Innovation Commission (201604020020)
Received: 1 March 2018
Accepted: 27 June 2018
First Online: 14 August 2018
Ethics approval and consent to participate
: This study and all protocols used conformed to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected in an a priori approval by the Human Research Committee of the Hereditary Neurological Disease Clinics of The First Affiliated Hospital, Sun Yat-sen University. Informed consent was obtained from each patient included in the study.
: The adult patients and the parents of the children described in this article provided consent for participation in the study and for publishing the obtained results.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.